Women's Health
Page 1 • 3 itemsGain critical intelligence on global women's health pharmaceutical markets. Drive strategic BD and investment decisions with expert analysis.
Viatris Presents Six Studies on Low-Dose Estrogen Contraceptive Patch at ACOG 2026
Viatris showcases clinical data for investigational weekly contraceptive patch at American College of Obstetricians and Gynecologists meeting May 1-3.
FDA Encourages Testosterone Therapy Expansion for Low Libido in Men with Hypogonadism
FDA takes initial step to advance testosterone replacement therapy for low libido in men with idiopathic hypogonadism, encouraging sponsors to pursue new indication.
Vistagen Receives FDA Approval to Advance Refisolone Phase 2 Trial for Menopause Hot Flashes
Vistagen gets FDA clearance to proceed with Phase 2 clinical development of Refisolone, an intranasal treatment for vasomotor symptoms in menopause.